Not applicableStudy completedNCT01780857What this trial is testingImmune Signature of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Baylor Research Institute 30
Large-scale testing (Phase 3)Study completedNCT00353119What this trial is testingA Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar PustulosisWho this might be right forPalmoplantaris Pustulosis Innovaderm Research Inc. 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367What this trial is testingTofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Testing effectiveness (Phase 2)Looking for participantsNCT07013201What this trial is testingA 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis LEO Pharma 135
Testing effectiveness (Phase 2)Study completedNCT00301002What this trial is testingStudy to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar PustulosisWho this might be right forPsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more The Guenther Dermatology Research Centre 15
Not applicableUnknownNCT04566471What this trial is testingPalmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of PrevalenceWho this might be right forPalmoplantar PustulosisGeneralized Pustular Psoriasis Peking University Third Hospital 200
Not applicableStudy completedNCT04459507What this trial is testingA Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanWho this might be right forPalmoplantar Pustulosis Janssen Pharmaceutical K.K. 276
Post-approval studies (Phase 4)Looking for participantsNCT07503652What this trial is testingClinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) First Hospital of China Medical University 10
Testing effectiveness (Phase 2)Study completedNCT04015518What this trial is testingTest How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Boehringer Ingelheim 152
Large-scale testing (Phase 3)Looking for participantsNCT07219420What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis UCB Biopharma SRL 320
Not applicableLooking for participantsNCT05994976What this trial is testingCollection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersWho this might be right forAcneAtopic DermatitisChronic Hand Eczema+3 more Innovaderm Research Inc. 500
Large-scale testing (Phase 3)Study completedNCT04451720What this trial is testingStudy of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) AbbVie 119
Large-scale testing (Phase 3)Study completedNCT02008890What this trial is testingPalmoplantar Pustular Psoriasis Efficacy and Safety With SecukinumabWho this might be right forPalmoplantar Pustular Psoriasis Novartis Pharmaceuticals 237
Post-approval studies (Phase 4)Ended earlyNCT05710185What this trial is testingDeucravacitinib for the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Brigham and Women's Hospital 3
Large-scale testing (Phase 3)Study completedNCT02641730What this trial is testingAn Efficacy and Safety of Guselkumab in Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Janssen Pharmaceutical K.K. 159
Not applicableLooking for participantsNCT07552454What this trial is testingPicankibart in Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Xijing Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04493424What this trial is testingTest Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With SpesolimabWho this might be right forPalmoplantar Pustulosis Boehringer Ingelheim 108
Testing effectiveness (Phase 2)Ended earlyNCT05194839What this trial is testingA Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Aristea Therapeutics, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT01794117What this trial is testingAnakinra for Inflammatory Pustular Skin DiseasesWho this might be right forSneddon-WilkinsonAcrodermatitis Continua of HallopeauPustular Psoriasis+1 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 18
Not applicableEnded earlyNCT07000630What this trial is testingEfficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Peking University First Hospital 3